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Abstract
Cowden syndrome is a rare autosomal
dominant familial cancer syndrome with a
high risk of breast cancer. The most impor-
tant clinical features include carcinomas of
the breast and thyroid, and hamartomatous
polyps of the gastrointestinal tract. There
are characteristic mucocutaneous features
which allow early recognition of the disease
and are generally present before internal
malignancies develop. We report on a wom-
an in whom the diagnosis of Cowden syn-
drome was first made after she had been
treated for both breast cancer and melano-
ma.
Copyright © 2001 S. Karger AG, Basel
Case Report
A 64-year-old woman was referred to our
outpatient clinic because of cosmetically dis-
turbing facial papules. According to her his-
tory she had developed progressive symme-
trical papules especially in the mid-face for
more than 20 years. Twelve years ago a CO2
laser treatment had been performed else-
where with only short-lasting cosmetic im-
provement. Her medical history included a
mastectomy on the right side because of an
infiltrating intraductal carcinoma in 1981,
malignant melanoma in 1988 and intestinal
bleeding of unknown etiology in 1992 and
again in January 2000. Gynecological exam-
ination following postmenopausal bleeding
in 1986 showed no relevant abnormalities.
There were no family members with sim-
ilar conditions. The 92-year-old mother of
the patient is apparently healthy. Her father
died at 56 years of age but had no skin
lesions. Her 39-year-old daughter has a his-
tory of fibrocystic disease of the breasts.
Physical examination disclosed multiple
dome-shaped, skin-colored papules on the
nose and in the nasolabial groove (fig. 1),
some with a filiform appearance. Similar
lesions were found periorally and in the
retroauricular region (fig. 2). Many of these
lesions were examined microscopically.
They all showed follicular structures with
prominent perifollicular fibrosis (fig. 3).
Multiple papular lesions were also identified
on the buccal and gingival mucosa creating a
cobblestoned appearance (fig. 4). Additional
findings included superficial keratoses on a
slightly erythematous base on the right later-
al ankle (fig. 5) and isolated small palmo-
plantar punctate keratodermas. Further ex-
amination by her gynecologist and family
physician (including ultrasonography of the
thyroid gland and of the abdomen) revealed
no further abnormalities. Gastroscopy and
colonoscopy were refused by the patient.
Laboratory examinations (complete blood
count, erythrocyte sedimentation rate, thy-
roid function tests, stool guaiac) were normal
or negative.
Physical examination of her daughter re-
vealed only tiny nasolabial papules (1 mm;
fig. 6) without further signs of the disease.
Discussion
Cowden syndrome (CS), also known as
Cowden disease or multiple hamartoma syn-
drome (MIM 158350), is a rare cancer-asso-
ciated genodermatosis with an autosomal
dominant pattern of inheritance and vari-
able expressivity. This disease was initially
described in 1963 by Lloyd and Dennis [1]
and was named after their patient Rachel
Cowden who died due to her breast cancer.
Nine years later, Weary et al. [2] defined the
syndrome as characterized by a variety of
hamartomatous lesions with multiple organ
system involvement, affecting tissues de-
rived from ectodermal, endodermal and me-
sodermal tissue layers, with a slight female
predominance.
Since then, over 150 cases of CS have
been reported in the literature with the char-
acteristic mucocutaneous features present in
almost 100% of the cases, including warty
facial papules (usually trichilemmomas),
oral papillomatosis and acral keratoses [3–
5]. Salem and Steck [6] proposed diagnostic
criteria for multiple hamartoma syndrome
which included major criteria (facial papules
and oral papillomatosis), minor criteria
(acral keratoses and palmoplantar keratoses)
and family history. Diagnosis was consid-
ered definite in the presence of 2 major crite-
ria, 1 major and 1 minor, 1 major and a posi-
tive family history, or 2 minor and a positive
family history. Our patient had 2 major cri-
teria and 2 minor criteria. Barax et al. [7]
proposed inclusion of sclerotic fibromas,
previously described in detail by Starink et
al. [8], as an additional major criterion. In
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Fig. 1. Verrucous and dome-shaped papules on the nose and in the
nasolabial groove.
Fig. 2. Grouped retroauricular papules.
Fig. 3. Histology of a nasal papule showing perifollicular fibroma.
Fig. 4. Closely set papules with a cobblestone pattern on the oral
mucosa.
Fig. 5. Superficial keratoses on the right lateral ankle.
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1998, the International Cowden Syndrome
Consortium operational criteria delineated
more detailed criteria for the diagnosis of CS
(in Tsao [9]), which also included, among
other diagnoses, breast cancer, thyroid can-
cer, macrocephaly and Lhermitte-Duclos
disease (table 1).
Most often the characteristic skin signs
develop in the 2nd and 3rd decades, but age
at onset may vary from 4 to 75 years [10] in
relation with the variability of the circum-
stances of discovery and the variability of
expressivity. Our patient noticed the first
papules after the age of 40. Mucocutaneous
findings are a prominent feature of the dis-
ease and present in every patient [4]. A
detailed classification into 6 groups of skin
lesions (lichenoid papules, acral keratoses,
translucent keratoses of the palm, verrucous
lesions, papillomatous lesions and mixed le-
sions) was made by Gianadda in her thesis
[11]. Newer publications distinguish only be-
tween facial papules, acral keratoses, palmo-
plantar keratoses and mucocutaneous le-
sions according to Salem and Steck [6]. Fa-
cial papules are the most frequent lesions
and can be found in up to 86% of cases [5],
preferentially localized in periorificial re-
gions, sometimes extending into the nostrils.
Histologically, the lesions frequently show
nonspecific hair follicle proliferations [12],
as we found in our patient, or may reveal tri-
chilemmomas. Acral verrucous hyperkerato-
sis on the extensor sides of the extremities
and palmoplantar translucent keratoses are
seen in about 28 and 20%, respectively [4].
Involvement of the mucosa is very impor-
tant for diagnosis and is present in over 80%
[4, 12]. Usually mucocutaneous lesions are
present in multiple locations, particularly
the buccal and gingival mucosa, where co-
alescent lesions lead to the characteristic
cobblestone-like pattern [4] in 40% of pa-
tients, as in our case. Extension to the oro-
pharynx, larynx, tongue and nasal mucosa
may occur. Less often there may be anogeni-
tal involvement. Mucocutaneous lesions
usually develop after facial lesions [10]. Fur-
ther associated cutaneous findings include
lipomas [7], hemangiomas [12], xanthomas
[13], vitiligo [3, 13, 14], neuromas [7, 12],
café au lait spots [15], periorificial and acral
lentigines [16] and acanthosis nigricans [7].
Differential diagnosis of the cutaneous
findings should include tuberous sclerosis,
Gardner syndrome, epidermodysplasia ver-
ruciformis (Lewandowski-Lutz), Brooke
syndrome, neurofibromatosis type 1 and
multiple fibrofolliculomas (Birt-Hogg-Dubé
syndrome). The biopsies from our patient’s
facial papules more closely resembled fibro-
folliculomas, as seen in Birt-Hogg-Dubé syn-
drome. Although we have never found a typi-
cal trichilemmoma in our patient, we are still
confident she has CS. The nature of the follic-
ular proliferations in many of the cancer-asso-
ciated genodermatoses remains unclear and
overlaps in histological pattern are not unusu-
al. Birt-Hogg-Dubé patients have an in-
creased risk of renal cell carcinoma [17] and
do not have hyperkeratotic palmoplantar pits
or cobblestoning of the oral mucosa [18].
Although nearly every internal malignan-
cy has been reported in association with CS
[9], breast cancer is most frequent occurring
in approximately 22% of women [12]. The
onset of breast cancer occurs at the same age
as in patients without CS [12, 19]. Our
patient was operated on for breast cancer at
the age of 45 years and her daughter has a
history of fibrocystic disease, which is seen
concomitantly with carcinoma in 53% of
female patients [3]. The importance of fibro-
cystic disease as a probable precursor lesion
to incipient invasive carcinoma was stressed
by Barax et al. [7]. The most frequently
reported extracutaneous manifestation is
thyroid disease, occurring in approximately
two thirds of patients [3] including multino-
dular goiter, thyroidal dysfunction, thyroidi-
tis and thyroid cancer [20], which represents
the second most common associated carci-
noma arising in 7% [21].
Intestinal tract involvement with hamar-
tomatous polyps is seen in 40–60% of pa-
tients [10, 12, 22]. This probably reflects an
underestimation since intestinal lesions are
often asymptomatic [10] and many reported
cases have not had extensive gastrointestinal
evaluation [7, 10]. A few cases of adenocarci-
noma of the colon have been reported in
patients with CS, but this association is
usually considered to be coincidental be-
cause of the high frequency of colorectal can-
cer in the general population. Recently pub-
lished cases suggest a possible relation to
familial adenomatous polyposis and heredi-
tary nonpolyposis colorectal cancer [23]. In








Major criteria Breast cancer
Thyroid cancer, especially follicular thyroid carcinoma
Macrocephaly 
Hamartomatous outgrowths of cerebellum
(Lhermitte-Duclos disease)
Minor criteria Thyroid lesions (e.g. adenoma or goiter)
Mental retardation (IQ ^ 75)
Hamartomatous intestinal polyps
Fibrocystic disease of the breast
Lipomas
Fibromas
Genitourinary tumors or malformations
Operational diagnosis
for individual
(1) Mucocutaneous lesions alone if
(a) 66 facial papules with 63 trichilemmomas
(b) Cutaneous facial papules and oral mucosal papillomatosis
(c) Oral mucosal papillomatosis and acral keratoses
(d) 6 or more palmar/plantar keratoses
or
(2) 2 major criteria but one must include macrocephaly or
Lhermitte-Duclos disease
or
(3) 1 major and 3 minor criteria
or
(4) 4 minor criteria
Breast
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our patient the source of intestinal bleeding
could not be found by colonoscopy in 1992.
Malignant melanoma has been described in
a few cases [24]. Associated extracutaneous
manifestations and neoplasias are listed in
table 2.
An autosomal dominant pattern of inher-
itance was first suggested by Weary et al. [2]
and later confirmed by Starink et al. [12].
The apparently sporadic cases observed [6]
probably represent de novo mutations. In
1996, the CS locus was mapped to human
chromosome 10q22–23 by Nelen et al. [25].
Independently a mutated tumor suppressor
gene PTEN (= phosphatase and tensin ho-
molog deleted on chromosome 10, also
called MMAC1) was found at chromosome
10q23 in multiple solid advanced cancers
[26, 27]. Subsequently inactivating germline
mutations of PTEN were found in patients
with CS [28, 29]. A multitude of different
PTEN mutations in CS patients – scattered
over the entire gene – have been reported
[30]. Whether these genotypic differences
cause phenotypic differences remains un-
clear. CS overlaps with several other hamar-
tomatous syndromes. Lhermitte-Duclos
disease, which is characterized by hamarto-
matous outgrowths of the cerebellum, was
considered a distinct entity but is now con-
sidered a component of CS [31]. Recently
mutations and deletions of PTEN have also
been found in 38% of primary and in 58% of
metastatic tumors, which may contribute to
the development and progression of malig-
nant melanoma [32]. Bannayan-Riley-Ru-
valcaba syndrome (macrocephaly, vascular
malformations, multiple lipomas, gastroin-
testinal polyps, thyroid disease and speckled
penile pigmentation) exhibits a number of
clinical similarities to CS [21, 33], and recent
studies have demonstrated that these 2 dis-
eases are allelic disorders at the PTEN locus
on chromosome 10q [21, 34]; however, Ban-
nayan-Riley-Ruvalcaba syndrome lacks the
high penetrance of cancer seen with CS.
Treatment of facial papules with topical
5-fluorouracil, oral retinoids, electrosurgery,
cryosurgery, dermabrasion and laser abla-
tion [4, 14, 19, 35] is often unsatisfactory
and mostly with only temporary effects.
There is no known therapy to actually pre-
vent the development of carcinoma. Base-
line studies should include thyroid function
tests, thyroid scanning, complete blood
count, urinalysis, mammography and chest
radiography [19, 36]. Due to the low poten-
tial for malignant degeneration of gastroin-
testinal polyps, screening in the absence of
symptoms is not generally indicated [37].
Further investigations by fine-needle aspira-
tion, surgical biopsy or magnetic resonance
imaging should be based on symptoms or
abnormalities found in a thorough physical
examination.
Cutaneous lesions are the most impor-
tant markers for CS, since they are present in
almost every patient and frequently appear
prior to the development of any internal dis-
ease. Especially in the era of common laser
treatments for cosmetic purposes, even in
the absence of a clear diagnosis, dermatolog-
ists play an important role in making an ear-
ly diagnosis which should lead to the earlier
diagnosis and more effective treatment of
the associated neoplasms.
Table 2. Benign and malignant extracutaneous manifestations in CS
Malignant Benign










Gastrointestinal tract Adenocarcinoma of the colon Polyposis 
Hepatocellular carcinoma Diverticula of colon and sigmoid
Ganglioneuromas
Hepatic hamartomas
Urogenital system Cervical cancer Vulvar and vaginal cysts
Adenocarcinoma of the uterus Uterine leiomyomas
Ovarian carcinoma Ovarian cysts
Transitional carcinoma of the Irregular menses










Skeletal Adenoid facies 
Bone cysts
Craniomegaly 





Miscellaneous Acute myelogenous leukemia Atrial septal defect
Non-Hodgkin’s lymphoma Pulmonary hamartomas
Liposarcoma Mental retardation
Lung adenocarcinoma Hypoplastic uvula
Renal cell carcinoma
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